YUCAIPA, Calif., Aug. 26, 2008 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (the "Company") (Pink Sheets:IGTG) announced today that its previously disclosed one for six hundred reverse stock split of its common stock will become effective as of the open of business on August 27, 2008. In connection with the reverse stock split, the Company's new stock symbol for its post-reverse common stock is ITEC and the new CUSIP number is 45684G 300.
The Company's transfer agent will act as "exchange agent" for purposes of implementing the exchange of stock certificates. Fractional shares created as a result of the stock split will be rounded up to the next whole share. The Company's transfer agent is Executive Registrar & Transfer, Inc. located at 3615 South Huron Street, Suite 104, Englewood, CO 80110 where its telephone number is (303) 783-9055 and its facsimile number is (303) 783-0852.
For more information please visit:
About Ingen Technologies, Inc.
Ingen is an emerging public company that introduced Oxyview(r) into the respiratory market in 2007; the world's first in-line oxygen flow meter. The company has expanded its distribution in North America and Asia, all of which reflect a multitude of cultures, nationalities, religions, expertise and ideas. Ingen has branded the Oxyview(r) with every major professional publication, and has gained the support from national recognized affiliates. The Company continues to adopt new OEM partners and expand the hospital based Group Purchasing Organizations as a part of the expansion program for distribution.
According to the 2002 CDC Report, there are approximately 32 million people living in the United States that suffer from Chronic Obstructive Pulmonary Disease, more commonly known as "COPD". COPD is the major cause of hospitalizations and the fifth leading cause of death in the United States. A large portion of the COPD patients receive oxygen therapy. Ingen Technologies owns the patents and trademarks for Oxyview(r) and OxyAlert(r), and there are no other products that compete or simulate either of these two products within the medical industry.
The Ingen Technologies, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=2472
Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.
A Member of the Better Business Bureau A Member of the Chamber of Commerce A Licensed Business in the City of Yucaipa A Registered & Licensed Manufacturer with FDA/DHS